Hi everyone,
I have updated our website article about the COVID-19 treatments for those who are at higher risk for severe illness from COVID-19 infection. lupusuk.org.uk/covid-19-tre...
There have been a couple of important changes:
1.Lateral flow tests are now accepted as confirmation of COVID-19 infection
This development means that, if you experience symptoms of COVID-19, you can potentially access the treatments quicker. To be effective, these treatments must be started as soon as possible after infection (within 5 days typically). By accepting lateral flow test results this will reduce the delay by 24-48 hours. This especially good news for people who have not received priority PCR tests after being identified as eligible for the treatments.
It is still advised to have a PCR test if you have symptoms of COVID-19 because lateral flow tests are not as accurate as PCR tests.
2.Nirmatrelvir and ritonavir (Paxlovid) has been added as a first-line COVID-19 treatment
In many cases, Paxlovid will be offered instead of the antibody infusion, sotrovimab. Paxlovid is an oral treatment meaning that it can be taken without having to attend a hospital. However, it is important to note that Paxlovid has several contraindications with prescribed, over-the-counter and complementary treatments. It is therefore very important that, when being assessed for treatment by a COVID-19 Medicines Delivery Unit (CMDU), a person discloses ALL medications/treatments they are taking. It may be helpful to have a list prepared ahead of the assessment.
If you have any questions about these changes, or want to share your experiences in accessing these treatments, please comment below.